[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GR3015457T3 - Substituted mandelic acid derivatives as 5-lipoxygenase inhibitors. - Google Patents

Substituted mandelic acid derivatives as 5-lipoxygenase inhibitors.

Info

Publication number
GR3015457T3
GR3015457T3 GR940404001T GR940404001T GR3015457T3 GR 3015457 T3 GR3015457 T3 GR 3015457T3 GR 940404001 T GR940404001 T GR 940404001T GR 940404001 T GR940404001 T GR 940404001T GR 3015457 T3 GR3015457 T3 GR 3015457T3
Authority
GR
Greece
Prior art keywords
acid derivatives
mandelic acid
substituted mandelic
lipoxygenase inhibitors
substituted
Prior art date
Application number
GR940404001T
Other languages
English (en)
Inventor
Klaus-Helmut Dr Mohrs
Siegfried Dr Raddatz
Michael Dr Matzke
Romanis Fruchtmann
Armin Dr Hatzelmann
Christian Dr Kohlsdorfer
Reiner Pro Mueller-Peddinghaus
Pia Dr Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GR3015457T3 publication Critical patent/GR3015457T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Measurement Of Force In General (AREA)
  • Sewage (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Moulding By Coating Moulds (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Manufacture And Refinement Of Metals (AREA)
GR940404001T 1991-08-29 1995-03-20 Substituted mandelic acid derivatives as 5-lipoxygenase inhibitors. GR3015457T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4128681A DE4128681A1 (de) 1991-08-29 1991-08-29 Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
GR3015457T3 true GR3015457T3 (en) 1995-06-30

Family

ID=6439400

Family Applications (1)

Application Number Title Priority Date Filing Date
GR940404001T GR3015457T3 (en) 1991-08-29 1995-03-20 Substituted mandelic acid derivatives as 5-lipoxygenase inhibitors.

Country Status (21)

Country Link
US (1) US5292769A (el)
EP (1) EP0529450B1 (el)
JP (1) JPH05194402A (el)
KR (1) KR930004270A (el)
AT (1) ATE115949T1 (el)
AU (1) AU643628B2 (el)
CA (1) CA2076929A1 (el)
CZ (1) CZ281501B6 (el)
DE (2) DE4128681A1 (el)
DK (1) DK0529450T3 (el)
ES (1) ES2065737T3 (el)
FI (1) FI101222B1 (el)
GR (1) GR3015457T3 (el)
HU (1) HU214577B (el)
IL (1) IL102949A (el)
MX (1) MX9204748A (el)
MY (1) MY110206A (el)
RU (1) RU2066315C1 (el)
SK (1) SK263992A3 (el)
TW (1) TW207995B (el)
ZA (1) ZA926536B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
US5512581A (en) * 1994-07-18 1996-04-30 Abbott Laboratories Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US8719041B2 (en) * 2002-06-10 2014-05-06 Ebay Inc. Method and system for customizing a network-based transaction facility seller application
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
AU2004298486A1 (en) 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
WO2008067566A1 (en) 2006-11-30 2008-06-05 Amira Pharmaceuticals, Inc. Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
EP3102209B1 (en) 2014-02-04 2021-04-07 Bioscience Pharma Partners, LLC Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Also Published As

Publication number Publication date
EP0529450A1 (de) 1993-03-03
US5292769A (en) 1994-03-08
CA2076929A1 (en) 1993-03-01
HUT67137A (en) 1995-02-28
ATE115949T1 (de) 1995-01-15
DE59201013D1 (de) 1995-02-02
SK279066B6 (sk) 1998-06-03
JPH05194402A (ja) 1993-08-03
RU2066315C1 (ru) 1996-09-10
EP0529450B1 (de) 1994-12-21
HU214577B (hu) 1998-04-28
HU9202780D0 (en) 1992-12-28
ES2065737T3 (es) 1995-02-16
ZA926536B (en) 1993-03-05
FI923841A0 (fi) 1992-08-27
KR930004270A (ko) 1993-03-22
IL102949A0 (en) 1993-01-31
IL102949A (en) 1997-02-18
AU643628B2 (en) 1993-11-18
SK263992A3 (en) 1998-06-03
FI101222B (fi) 1998-05-15
TW207995B (el) 1993-06-21
CZ263992A3 (en) 1993-08-11
DK0529450T3 (da) 1995-05-15
CZ281501B6 (cs) 1996-10-16
FI923841A (fi) 1993-03-01
FI101222B1 (fi) 1998-05-15
AU2137192A (en) 1993-03-04
MX9204748A (es) 1993-02-01
DE4128681A1 (de) 1993-03-04
MY110206A (en) 1998-02-28

Similar Documents

Publication Publication Date Title
HU9401415D0 (en) Enzofuranyl- and -thiophenyl-alkane-carboxylic acid derivatives, pharmaceutical compositions contaning them, and process for producing them
IL148288A0 (en) Indolealkanol ester and indolealkylamide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU2993892A (en) Novel azaheterocyclylmethyl-chromans
GR3015457T3 (en) Substituted mandelic acid derivatives as 5-lipoxygenase inhibitors.
NO940523L (no) Nye pyrazin-derivater
BG100069A (en) Amidine derivatives containing heterocylic groups, their preparation and application
MY117381A (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
MY108716A (en) New isobutyl-substituted methanesulphonyl-quinolyl- mehtoxyphenyl- cycloalkylacetamides.
HUT50461A (en) Process for producing imidazole derivatives inhibiting dopamin-beta-hydroxylase and pharmaceutical compositions comprising such compounds
JPS51144790A (en) Process for preparing l-cysteine derivatives
JPS5293755A (en) Preparation of carboxylic acid derivatives
JPS53116373A (en) Preparation of 5-(4-hydroxyphenyl)hydantoin
JPS5324089A (en) Cultivation of basidiomycetes
JPS52118468A (en) Purification of imidazole derivatives by means of ion-exchange resin
JPS5411296A (en) Preparation of uricase by fermentation
JPS52156992A (en) Preparation of l-serine
JPS5352679A (en) Decomposition of alginic acid sodium salt
JPS549212A (en) Preparation of hydroxycitronellal
JPS53121749A (en) Preparation of 5-alkylbenzophenonehydydrazone
JPS5399315A (en) Remedies against malignant tumors
JPS5362836A (en) Anticarcinogens
JPS51148093A (en) Process for preparing l-tryptophan by fermentation
JPS52156878A (en) Preparation of 1-(2-tetrahydrofuryl-uracils)
UA19295A (uk) СПОСІБ ОДЕРЖАHHЯ omega-ГІДРОПЕРФТОРАЛКАHО-ІЛФТОРИДІВ
JPS52118443A (en) Synthesis of 3-methyl-3-(4-isobutylphenyl)pyruvic acid